MarketLens

What's Behind Corcept's Recent Legal Troubles

6 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What's Behind NuScale Power's Recent Volatility and Legal Troubles

6 months ago

What Triggered Kyndryl's Recent Stock Plunge and Legal Troubles

6 months ago

What's Behind Paysafe's Latest Legal Headwinds

5 months ago

What's Behind the Recent Legal Challenges to Costco's Iconic Rotisserie Chicken

6 months ago

Why Is Corcept (CORT) Down 1.2% Since Last Earnings Report?

Corcept (CORT) shares fell 1.2% in the 30 days since its last earnings report, as investors weigh the company's financial results and near-term outlook.

CORT

Stock News•1 months ago

As Lilly and Novo Clash in Court, Wall Street Is Eyeing This Bigger Prize

Eli Lilly and Novo Nordisk's legal clash is intensifying, but Wall Street is more focused on their laboratory developments, which could determine future market leadership.

LLY

Stock News•1 months ago

Will Myqorzo Drive Cytokinetics Higher Despite Competitive Pressure?

Cytokinetics rose after Myqorzo's FDA approval, driven by early US uptake, European expansion, and lifecycle studies. Commercial momentum faces competitive pressure.

CYTK

Stock News•1 months ago

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals (CRNX) faces an investigation into its $85/share sale to Vertex (VRTX), after a law firm alleged the board may have breached fiduciary duties by failing to conduct a fair pro...

CRNX